dvm360

FDA approves first generic florfenicol–flunixin injectable (nixiFLOR) for bovine respiratory disease

The FDA has approved nixiFLOR, the first generic florfenicol-flunixin injectable, for treatment of bovine respiratory disease and control of associated fever in beef and nonlactating dairy cattle.
Drovers

nixiFLOR Injection Approved by the FDA for Bovine Respiratory Disease Treatment

The new generic drug has been approved for treatment of bovine respiratory disease and associated pyrexia in beef and ...

FDA approves first treatment for Menkes disease in children

The U.S. Food and Drug Administration has approved the Zycubo (copper histidinate) injection as the first treatment for ...
Seeking Alpha

argenx Announces U.S. Food and Drug Administration Approval of VYVGART Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) Injection for Subcutaneous Use in Generalized ...

Amsterdam, the Netherlands—June 20, 2023—argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today ...